HOTLINE 24/7/365 UK: +44 (0) 1483 212150
Nov 19

The co-creation of value using automation and robotic system processes

The health and medicinal industry is currently at a turning-point in technology, constantly investigating new ways to incorporate automation, robotics and A.I into formal practice.

However, this topic has mixed industry opinions, with many industry professionals arguing on the advantages and disadvantages of such technological innovations.


There is a strong argument for the medicinal industry’s movement towards technological innovations, with many professionals believing that the implementation of such advancements will aid the deliverance of an enhanced level of care for patients. For instance, there is a confidence that technology will improve processes within Pharmacovigilance, with data capture and processing efficiency expected to evolve the role of the modern professional; thus, allowing Pharmacovigilance Associates and similar roles to focus their time and expertise on higher skilled tasks.


However,  whilst serious patient harm may still occur in both user-controlled and automated system processes, there remains an increased risk involved when automated technological systems are involved. In a recent study, within the Journey of Patient Safety, it was found that 80% of all electronic health record claims lead to severe patient harm, with 58% of electronic health record related claims directly resulting from technical faults and only 14% of issues deriving from hybrid health records conversion issues.


Altogether, despite being quicker and cheaper to redesign (in the event of an error) than the process of retraining a human user, it is conclusive that the industry opinion is that proper training and synergy between automation and human care will provide the best outcome – allowing for the co-creation of value for both the patient and the medicinal provider.

PharSafer Comment:

PharSafer, as an innovative company, has long worked in the area of automation and systems improvements; such that we have developed robotic and computer system solutions, maintaining a ‘hands off’ mentality, with the mantra that systems improvements should:

  • Reduce human errors
  • Prevention of poor data quality inclusion
  • Speed up processes
  • Provide global consistency
  • Aid regulatory compliance
  • Reduce the requirement of human intervention

Consequently, this provides for the assignment of personnel into more cerebral and experience related functions.

PharSafer are working on such inventions at present, which we hope will be commercialised for 2020 and utilised extensively, within the Pharmaceutical industry.


Share this News item: